Clinical trial
Methylprednisolone With or Without Doxorubicin in Treating Patients With…
NCT00003682 · UNICANCER, Other · Terminated
Key facts
| NCT number | NCT00003682 |
|---|---|
| Title | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer |
| Official title | Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study |
| Lead sponsor | UNICANCER, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride, methylprednisolone |
| Enrollment | 160 |
| Start date | Oct 1, 1998 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | Jan 27, 2004 |
| Last update posted | Jun 23, 2016 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: